Thymoglobulin® Pharmacokinetics in Patients Undergoing Hematopoietic Stem Cell Transplantation

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(2 sites)

France

Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon

Centre Hospitalier Lyon Sud, Pierre-Bénite